Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Microbial Preparations (P… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Microbial Preparations (Probiotics) for the Prevention of Clostridium difficile Infection in Adults and Children: An Individual Patient Data Meta-analysis of 6,851 Participants

Artikel i vetenskaplig tidskrift
Författare B. C. Johnston
L. Lytvyn
C. K. F. Lo
S. J. Allen
D. L. Wang
H. Szajewska
M. Miller
S. Ehrhardt
J. Sampalis
D. G. Duman
P. Pozzoni
A. Colli
Elisabeth Lönnermark
C. P. Selinger
S. Wong
S. Plummer
M. Hickson
R. Pancheva
S. Hirsch
B. Klarin
J. Z. Goldenberg
L. Wang
L. Mbuagbaw
G. Foster
A. Maw
B. Sadeghirad
L. Thabane
D. Mertz
Publicerad i Infection Control and Hospital Epidemiology
Volym 39
Nummer/häfte 7
Sidor 771-781
ISSN 0899-823X
Publiceringsår 2018
Publicerad vid Institutionen för biomedicin, avdelningen för infektionssjukdomar
Sidor 771-781
Språk en
Länkar dx.doi.org/10.1017/ice.2018.84
Ämnesord antibiotic-associated diarrhea, placebo-controlled trial, double-blind, saccharomyces-boulardii, clinical-trial, efficacy, epidemiology, appropriate, guidelines, diagnosis, Public, Environmental & Occupational Health, Infectious Diseases, rding dn, 1986, archives of internal medicine, v146, p95
Ämneskategorier Samhällsmedicin, Infektionsmedicin

Sammanfattning

OBJECTIVE. To determine whether probiotic prophylaxes reduce the odds of Clostridium difficile infection (CDI) in adults and children. DESIGN. Individual participant data (IPD) meta-analysis of randomized controlled trials (RCTs), adjusting for risk factors. METHODS. We searched 6 databases and 11 grey literature sources from inception to April 2016. We identified 32 RCTs (n=8,713); among them, 18 RCTs provided IPD (n=6,851 participants) comparing probiotic prophylaxis to placebo or no treatment (standard care). One reviewer prepared the IPD, and 2 reviewers extracted data, rated study quality, and graded evidence quality. RESULTS. Probiotics reduced CDI odds in the unadjusted model (n=6,645; odds ratio [OR] 0.37; 95% confidence interval [CI], 0.25-0.55) and the adjusted model (n=5,074; OR, 0.35; 95% CI, 0.23-0.55). Using 2 or more antibiotics increased the odds of CDI (OR, 2.20; 95% CI, 1.11-4.37), whereas age, sex, hospitalization status, and high-risk antibiotic exposure did not. Adjusted subgroup analyses suggested that, compared to no probiotics, multispecies probiotics were more beneficial than single-species probiotics, as was using probiotics in clinical settings where the CDI risk is 5%. Of 18 studies, 14 reported adverse events. In 11 of these 14 studies, the adverse events were retained in the adjusted model. Odds for serious adverse events were similar for both groups in the unadjusted analyses (n=4,990; OR, 1.06; 95% CI, 0.89-1.26) and adjusted analyses (n=4,718; OR, 1.06; 95% CI, 0.89-1.28). Missing outcome data for CDI ranged from 0% to 25.8%. Our analyses were robust to a sensitivity analysis for missingness. CONCLUSIONS. Moderate quality (ie, certainty) evidence suggests that probiotic prophylaxis may be a useful and safe CDI prevention strategy, particularly among participants taking 2 or more antibiotics and in hospital settings where the risk of CDI is >= 5%.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?